Bausch Health Companies Inc. Common Stock (NY:BHC)

5.890 +0.090 (+1.55%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

November 18, 2024

Via ACCESSWIRE

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗

November 01, 2024

Via Benzinga

Bausch Health Announces Third Quarter 2024 Results

October 30, 2024

Via ACCESSWIRE

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

October 27, 2024

Via ACCESSWIRE

Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt ↗

October 26, 2024

IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders.

Via Benzinga

Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

August 13, 2024

Via ACCESSWIRE

Bausch Health Announces Second Quarter 2024 Results

July 30, 2024

Via ACCESSWIRE

Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags ↗

October 21, 2024

S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.

Via Benzinga

Topics Bankruptcy Stocks

Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces ↗

October 14, 2024

Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.

Via Benzinga

Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024

October 09, 2024

Via ACCESSWIRE

Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises

October 08, 2024

Via ACCESSWIRE

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

September 25, 2024

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

Via MarketBeat

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Bausch Health Responds to Market Rumors

July 24, 2024

Via ACCESSWIRE

Bausch Health Welcomes Two New Members to the Executive Leadership Team

July 19, 2024

Via ACCESSWIRE

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗

September 22, 2024

Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.

Via Benzinga

Topics Economy

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues ↗

September 16, 2024

Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.

Via Benzinga

Topics Supply Chain

Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It? ↗

September 16, 2024

Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.

Via Investor's Business Daily

Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens ↗

September 04, 2024

Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease.

Via Benzinga

Topics Economy

Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock ↗

August 02, 2024

Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing...

Via Benzinga

US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? ↗

August 01, 2024

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...

Via Benzinga

Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November ↗

August 01, 2024

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...

Via Benzinga

BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy ↗

July 24, 2024

Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism.

Via InvestorPlace

Topics Bankruptcy

Why Bausch health Shares Are Falling Today ↗

July 24, 2024

Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged...

Via Benzinga

Topics Bankruptcy

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Stocks Plummet After Tech Earnings, Manufacturing Data ↗

July 24, 2024

The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023.

Via Talk Markets

Topics Stocks

Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024

July 11, 2024

Via ACCESSWIRE

Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals

June 20, 2024

Via ACCESSWIRE

Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences

June 14, 2024

Via ACCESSWIRE

Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults

May 23, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.